BioCentury | Nov 22, 2016
Financial News

Fate completes private placement

...7.2 million shares of common stock at $2.66 to BVF Partners L.P., EcoR1 Capital LLC, Franklin Advisers...
BioCentury | Aug 15, 2016
Financial News

Fate Therapeutics completes private placement

...placement Raised: $10.3 million Shares: 5.3 million Price: $1.96 Shares after offering: 34.1 million Investors: Franklin Advisers...
BioCentury | Jun 15, 2015
Financial News

Arca biopharma completes private placement of units

...unit) Shares after offering: 63.2 million Placement agent: MTS Securities Investors: Venrock; New Enterprise Associates; Franklin Advisers...
BioCentury | Apr 13, 2015
Financial News

Edge Therapeutics completes venture financing

...financing Raised: $56 million Placement agents: Credit Suisse; Leerink Investors: Venrock; Sofinnova Partners; Janus Capital; Franklin Advisers...
BioCentury | Apr 10, 2015
Financial News

Edge raises $72.5M in additional series C rounds

...in a C-2 round led by Venrock. Sofinnova Ventures; Janus Capital Management; funds managed by Franklin Advisers...
BioCentury | Jan 12, 2015
Finance

Aduro's bolus of new investors

...untranched series D round last week from new investors that included OrbiMed, Janus Capital Management, Franklin Advisers...
BioCentury | Jan 12, 2015
Financial News

Aduro Biotech completes venture financing

...Type: Venture financing Raised: $51.4 million Placement agent: Leerink Partners Investors: OrbiMed Advisors; Janus Capital; Franklin Advisers...
BioCentury | Jan 6, 2015
Financial News

Aduro raises $51.4M in D round

...raised $51.4 million in a series D round. New investors included OrbiMed; Janus Capital Management; Franklin Advisers...
BioCentury | Aug 8, 2011
Finance

Dendreon's scalded investors

...1.5%); BlackRock Fund Advisors (1.4%); Invesco Advisers (1.4%); Columbia Management (1.4%); Sectoral Asset Management (1.3%); Franklin Advisers...
BioCentury | Apr 27, 2009
Finance

Avastin's tender mercies

...wouldn't disclose specific names. At year end, McCulloch's fund held 404,700 shares of Genentech, while Franklin Advisers...
Items per page:
1 - 10 of 10
BioCentury | Nov 22, 2016
Financial News

Fate completes private placement

...7.2 million shares of common stock at $2.66 to BVF Partners L.P., EcoR1 Capital LLC, Franklin Advisers...
BioCentury | Aug 15, 2016
Financial News

Fate Therapeutics completes private placement

...placement Raised: $10.3 million Shares: 5.3 million Price: $1.96 Shares after offering: 34.1 million Investors: Franklin Advisers...
BioCentury | Jun 15, 2015
Financial News

Arca biopharma completes private placement of units

...unit) Shares after offering: 63.2 million Placement agent: MTS Securities Investors: Venrock; New Enterprise Associates; Franklin Advisers...
BioCentury | Apr 13, 2015
Financial News

Edge Therapeutics completes venture financing

...financing Raised: $56 million Placement agents: Credit Suisse; Leerink Investors: Venrock; Sofinnova Partners; Janus Capital; Franklin Advisers...
BioCentury | Apr 10, 2015
Financial News

Edge raises $72.5M in additional series C rounds

...in a C-2 round led by Venrock. Sofinnova Ventures; Janus Capital Management; funds managed by Franklin Advisers...
BioCentury | Jan 12, 2015
Finance

Aduro's bolus of new investors

...untranched series D round last week from new investors that included OrbiMed, Janus Capital Management, Franklin Advisers...
BioCentury | Jan 12, 2015
Financial News

Aduro Biotech completes venture financing

...Type: Venture financing Raised: $51.4 million Placement agent: Leerink Partners Investors: OrbiMed Advisors; Janus Capital; Franklin Advisers...
BioCentury | Jan 6, 2015
Financial News

Aduro raises $51.4M in D round

...raised $51.4 million in a series D round. New investors included OrbiMed; Janus Capital Management; Franklin Advisers...
BioCentury | Aug 8, 2011
Finance

Dendreon's scalded investors

...1.5%); BlackRock Fund Advisors (1.4%); Invesco Advisers (1.4%); Columbia Management (1.4%); Sectoral Asset Management (1.3%); Franklin Advisers...
BioCentury | Apr 27, 2009
Finance

Avastin's tender mercies

...wouldn't disclose specific names. At year end, McCulloch's fund held 404,700 shares of Genentech, while Franklin Advisers...
Items per page:
1 - 10 of 10